We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

122 hedge funds and large institutions have $586M invested in Array Biopharma Inc in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 9

36% more capital invested

Capital invested by funds: $431M → $586M (+$155M)

12% more call options, than puts

Call options by funds: $4.84M | Put options by funds: $4.32M

9% more funds holding

Funds holding: 112 → 122 (+10)

9% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
122
Holders Change
+10
Holders Change %
+8.93%
% of All Funds
3.25%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
21
Increased
38
Reduced
35
Closed
9
Calls
$4.84M
Puts
$4.32M
Net Calls
+$517K
Net Calls Change
+$1.24M

Top Buyers

1
RG
Redmile Group
California
+$13.9M
2
First Manhattan
First Manhattan
New York
+$5.14M
3
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$3.96M
4
Axa
Axa
France
+$3.38M
5
O
OrbiMed
New York
+$3.34M

Top Sellers

1
BI
BVF Inc
California
-$8.32M
2
QF
QVT Financial
New York
-$8.03M
3
State Street
State Street
Massachusetts
-$5.9M
4
KIA
Kopp Investment Advisors
Minnesota
-$5.56M
5
AC
Apex Capital
California
-$4.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
51
Goldman Sachs
New York
$1.04M -$354K -89,530 -29%
AllianceBernstein
52
AllianceBernstein
Tennessee
$963K – – –
WMSA
53
Weiss Multi-Strategy Advisers
New York
$946K -$19.8K -5,000 -2%
OPPM
54
Opus Point Partners Management
New York
$946K +$791K +200,000 New
AL
55
Airain Ltd
Guernsey
$945K +$790K +199,761 New
HCM
56
Highbridge Capital Management
New York
$925K +$774K +195,712 New
PI
57
Putnam Investments
Massachusetts
$916K -$4.44K -1,122 -0.6%
TA
58
Teachers Advisors
New York
$842K – – –
Barclays
59
Barclays
United Kingdom
$829K +$750K +189,580 +1,098%
BFIC
60
Bedell Frazier Investment Counselling
California
$817K +$238K +60,250 +54%
HCM
61
Hollencrest Capital Management
California
$804K – – –
Wells Fargo
62
Wells Fargo
California
$725K -$181K -45,837 -23%
Swiss National Bank
63
Swiss National Bank
Switzerland
$681K +$24.9K +6,300 +5%
Connor, Clark & Lunn Investment Management (CC&L)
64
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$618K +$517K +130,600 New
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$578K +$21.1K +5,325 +5%
ProShare Advisors
66
ProShare Advisors
Maryland
$541K -$13.9K -3,511 -3%
B
67
Bailard
California
$497K – – –
Morgan Stanley
68
Morgan Stanley
New York
$483K -$563K -142,375 -58%
MLICM
69
Metropolitan Life Insurance Company (MetLife)
New York
$475K – – –
NFA
70
Nationwide Fund Advisors
Ohio
$451K -$8.28K -2,093 -2%
State Board of Administration of Florida Retirement System
71
State Board of Administration of Florida Retirement System
Florida
$402K – – –
AIG
72
American International Group
New York
$376K -$12.4K -3,135 -4%
VOYA Investment Management
73
VOYA Investment Management
Georgia
$366K – – –
Two Sigma Advisers
74
Two Sigma Advisers
New York
$352K +$295K +74,513 New
DekaBank Deutsche Girozentrale
75
DekaBank Deutsche Girozentrale
Germany
$338K -$25.7K -6,500 -8%
1 2
3
4 5

ARRY Hedge Fund Activity: Q4 2014 in Review

122 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q4 2014, worth a combined $586M — up 36% from $431M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ARRY positions and 9 closed out — a net gain of 12 holders — while 38 added to existing stakes and 35 trimmed.

The largest buyer was Redmile Group, adding an estimated $13.9M. The largest seller was BVF Inc, cutting an estimated $8.32M.

  • 122 institutional investors held Array Biopharma Inc (ARRY) as of Q4 2014, up from 112 in Q3 2014.
  • Funds reported $586M of Array Biopharma Inc stock for Q4 2014, up 36% quarter-over-quarter.
  • 21 funds opened new Array Biopharma Inc positions in Q4 2014 and 9 closed out, a net change of +12 holders.
  • The largest Array Biopharma Inc buyer in Q4 2014 was Redmile Group, an estimated $13.9M added.
  • The largest Array Biopharma Inc seller in Q4 2014 was BVF Inc, an estimated $8.32M sold.

Based on aggregated 13F filings for Q4 2014.